The congenital hyperinsulinism treatment market is evolving, driven by early diagnosis via neonatal screening, medical and surgical hormone therapies, and increasing research into genetic metabolic pathways. https://www.datamintelligence.com/research-report/congenital-hyperinsulinism-treatment-market